Conmana (icotinib) / Betta Pharma |
MINT, NCT01514877: Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer |
|
|
| Completed | 2 | 20 | RoW | Icotinib | Zhejiang Cancer Hospital | Lung Cancer, Metastatic Cancer | 07/14 | 07/14 | | |
|
NCT02726568: High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases |
|
|
| Recruiting | 2 | 30 | RoW | Icotinib, SRS | Betta Pharmaceuticals Co., Ltd. | Non-small Cell Lung Cancer, Brain Metastases | 12/21 | 12/22 | | |
NCT02820116: The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation |
|
|
| Recruiting | 2 | 67 | RoW | Icotinib, Conmana | Beijing Haidian Hospital, Peking University People's Hospital, 307 Hospital of PLA, 309th Hospital of Chinese People's Liberation Army | Non-small Cell Lung Cancer(NSCLC) | 04/23 | 04/23 | | |
NCT01516983: Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation |
|
|
| Completed | 1/2 | 15 | RoW | icotinib, BPI-2009, Conmana, Whole brain radiotherapy, RT, XRT, Radiotherapy, WBRT | Betta Pharmaceuticals Co., Ltd. | Non-small Cell Lung Cancer, Brain Metastases | 06/13 | 12/13 | | |
|
|